413 related articles for article (PubMed ID: 18928949)
1. Reendothelialization of tubular scaffolds by sedimentary and rotative forces: a first step toward tissue-engineered venous graft.
Wu YF; Zhang J; Gu YQ; Li JX; Wang LC; Wang ZG
Cardiovasc Revasc Med; 2008; 9(4):238-47. PubMed ID: 18928949
[TBL] [Abstract][Full Text] [Related]
2. [Preliminary in vivo evaluation of tissue engineered venous grafts fabricated based on endothelial progenitor cells].
Wu YF; Zhang J; Gu YQ; Li JX; Chen XS; Chen L; Chen B; Guo LR; Luo T; Liao CJ; Wu X; Yu HX; Wang ZG
Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):491-5. PubMed ID: 17686312
[TBL] [Abstract][Full Text] [Related]
3. Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells.
Fang NT; Xie SZ; Wang SM; Gao HY; Wu CG; Pan LF
Chin Med J (Engl); 2007 Apr; 120(8):696-702. PubMed ID: 17517187
[TBL] [Abstract][Full Text] [Related]
4. Construction of an autologous tissue-engineered venous conduit from bone marrow-derived vascular cells: optimization of cell harvest and seeding techniques.
Roh JD; Brennan MP; Lopez-Soler RI; Fong PM; Goyal A; Dardik A; Breuer CK
J Pediatr Surg; 2007 Jan; 42(1):198-202. PubMed ID: 17208565
[TBL] [Abstract][Full Text] [Related]
5. The fate of an endothelium layer after preconditioning.
Yazdani SK; Tillman BW; Berry JL; Soker S; Geary RL
J Vasc Surg; 2010 Jan; 51(1):174-83. PubMed ID: 20117500
[TBL] [Abstract][Full Text] [Related]
6. Cyclic flexure and laminar flow synergistically accelerate mesenchymal stem cell-mediated engineered tissue formation: Implications for engineered heart valve tissues.
Engelmayr GC; Sales VL; Mayer JE; Sacks MS
Biomaterials; 2006 Dec; 27(36):6083-95. PubMed ID: 16930686
[TBL] [Abstract][Full Text] [Related]
7. Fabrication of stents with endothelial function in vitro.
Zhao Q; Wei M; Zhao B
Scand Cardiovasc J; 2010 Apr; 44(2):76-81. PubMed ID: 19642053
[TBL] [Abstract][Full Text] [Related]
8. Shear-stress preconditioning and tissue-engineering-based paradigms for generating arterial substitutes.
Baguneid M; Murray D; Salacinski HJ; Fuller B; Hamilton G; Walker M; Seifalian AM
Biotechnol Appl Biochem; 2004 Apr; 39(Pt 2):151-7. PubMed ID: 15032735
[TBL] [Abstract][Full Text] [Related]
9. Tissue-engineered blood vessel graft produced by self-derived cells and allogenic acellular matrix: a functional performance and histologic study.
Yang D; Guo T; Nie C; Morris SF
Ann Plast Surg; 2009 Mar; 62(3):297-303. PubMed ID: 19240529
[TBL] [Abstract][Full Text] [Related]
10. Human dermal fibroblasts: a potential cell source for endothelialization of vascular grafts.
Karlsson LK; Junker JP; Grenegård M; Kratz G
Ann Vasc Surg; 2009; 23(5):663-74. PubMed ID: 19576728
[TBL] [Abstract][Full Text] [Related]
11. Tubular nanofiber scaffolds for tissue engineered small-diameter vascular grafts.
He W; Ma Z; Teo WE; Dong YX; Robless PA; Lim TC; Ramakrishna S
J Biomed Mater Res A; 2009 Jul; 90(1):205-16. PubMed ID: 18491396
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cell-based tissue engineering of small-diameter blood vessels.
Dong JD; Huang JH; Gao F; Zhu ZH; Zhang J
Vascular; 2011 Aug; 19(4):206-13. PubMed ID: 21784877
[TBL] [Abstract][Full Text] [Related]
13. Umbilical cord blood derived endothelial progenitor cells for tissue engineering of vascular grafts.
Schmidt D; Breymann C; Weber A; Guenter CI; Neuenschwander S; Zund G; Turina M; Hoerstrup SP
Ann Thorac Surg; 2004 Dec; 78(6):2094-8. PubMed ID: 15561042
[TBL] [Abstract][Full Text] [Related]
14. The independent role of cyclic flexure in the early in vitro development of an engineered heart valve tissue.
Engelmayr GC; Rabkin E; Sutherland FW; Schoen FJ; Mayer JE; Sacks MS
Biomaterials; 2005 Jan; 26(2):175-87. PubMed ID: 15207464
[TBL] [Abstract][Full Text] [Related]
15. Preclinical development of tissue-engineered vein valves and venous substitutes using re-endothelialised human vein matrix.
Teebken OE; Puschmann C; Breitenbach I; Rohde B; Burgwitz K; Haverich A
Eur J Vasc Endovasc Surg; 2009 Jan; 37(1):92-102. PubMed ID: 19008126
[TBL] [Abstract][Full Text] [Related]
16. Development of anti-atherosclerotic tissue-engineered blood vessel by A20-regulated endothelial progenitor cells seeding decellularized vascular matrix.
Zhu C; Ying D; Mi J; Li L; Zeng W; Hou C; Sun J; Yuan W; Wen C; Zhang W
Biomaterials; 2008 Jun; 29(17):2628-36. PubMed ID: 18377984
[TBL] [Abstract][Full Text] [Related]
17. A novel automated cell-seeding device for tissue engineering of tubular scaffolds: design and functional validation.
Mohebbi-Kalhori D; Rukhlova M; Ajji A; Bureau M; Moreno MJ
J Tissue Eng Regen Med; 2012 Oct; 6(9):710-20. PubMed ID: 21948700
[TBL] [Abstract][Full Text] [Related]
18. Decellularized and photooxidatively crosslinked bovine jugular veins as potential tissue engineering scaffolds.
Lü WD; Zhang M; Wu ZS; Hu TH
Interact Cardiovasc Thorac Surg; 2009 Mar; 8(3):301-5. PubMed ID: 19074454
[TBL] [Abstract][Full Text] [Related]
19. In vitro characterization of three-dimensional scaffolds seeded with human bone marrow stromal cells for tissue engineered growth of bone: mission impossible? A methodological approach.
Materna T; Rolf HJ; Napp J; Schulz J; Gelinsky M; Schliephake H
Clin Oral Implants Res; 2008 Apr; 19(4):379-86. PubMed ID: 18324959
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of in vivo endothelialization of tissue-engineered vascular grafts by granulocyte colony-stimulating factor.
Cho SW; Lim JE; Chu HS; Hyun HJ; Choi CY; Hwang KC; Yoo KJ; Kim DI; Kim BS
J Biomed Mater Res A; 2006 Feb; 76(2):252-63. PubMed ID: 16265638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
